Paper36819797
Highlights from ecancer Choosing Wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th-25th September 2022, Kathmandu, Nepal.
Poudyal BS and 3 others. Ecancermedicalscience, 2022. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Highlights from ecancer Choosing Wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th-25th September 2022, Kathmandu, Nepal. Papers, record 36819797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36819797
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Highlights from ecancer Choosing Wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th-25th September 2022, Kathmandu, Nepal.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30374970 | Association between progression-free survival and patients' quality of life in cancer clinical trials. | Int J Cancer | 2019 | https://conductscience.org/library/papers/30374970 | PubMed |
| 2 | 30528804 | A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology. | Eur J Cancer | 2019 | https://conductscience.org/library/papers/30528804 | PubMed |
| 3 | 33555940 | Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/33555940 | PubMed |
| 4 | 34325401 | Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals? | J Natl Compr Canc Netw | 2021 | https://conductscience.org/library/papers/34325401 | PubMed |
| 5 | 35985695 | Ensuring quality in contextualised cancer management guidelines for resource-constraint settings: using a systematic approach. | BMJ Glob Health | 2022 | https://conductscience.org/library/papers/35985695 | PubMed |
| 6 | 30241238 | What Global Oncology Needs: Mutual Learning and More Funding. | J Glob Oncol | 2018 | https://conductscience.org/library/papers/30241238 | PubMed |
| 7 | 33412270 | Have investigators forgotten how to write? | Ann Oncol | 2021 | https://conductscience.org/library/papers/33412270 | PubMed |
| 8 | 30385466 | Reporting harms more transparently in trials of cancer drugs. | BMJ | 2018 | https://conductscience.org/library/papers/30385466 | PubMed |
| 9 | 29508746 | Cancer groundshot: going global before going to the moon. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/29508746 | PubMed |
| 10 | 16740527 | The great medicines scandal. | BMJ | 2006 | https://conductscience.org/library/papers/16740527 | PubMed |
| 11 | 35440715 | Cancer treatments should benefit patients: a common-sense revolution in oncology. | Nat Med | 2022 | https://conductscience.org/library/papers/35440715 | PubMed |
| 12 | 27353411 | Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directions. | Haemophilia | 2016 | https://conductscience.org/library/papers/27353411 | PubMed |
| 13 | 32735488 | Overview of Delivery of Cancer Care in Nepal: Current Status and Future Priorities. | JCO Glob Oncol | 2020 | https://conductscience.org/library/papers/32735488 | PubMed |
| 14 | 33216359 | The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal. | Br J Haematol | 2021 | https://conductscience.org/library/papers/33216359 | PubMed |
| 15 | 35242221 | Clinical research in oncology: in memory of Professor Gordon McVie. | Ecancermedicalscience | 2022 | https://conductscience.org/library/papers/35242221 | PubMed |
| 16 | 32298471 | Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value. | Clin Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32298471 | PubMed |
| 17 | 33507236 | An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/33507236 | PubMed |
| 18 | 36273670 | Rules for the conduct of clinical trials need revision, but 'good clinical practice' requires much more. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36273670 | PubMed |
| 19 | 15143092 | Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15143092 | PubMed |
| 20 | 35182794 | Hematopoietic Stem Cell Transplantation in Nepal: International Partnership, Implementation Steps, and Clinical Outcomes. | Transplant Cell Ther | 2022 | https://conductscience.org/library/papers/35182794 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36819797
GET https://conductscience.org/api/papers/v1/36819797/references?page=2